Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
The American Journal of Gastroenterology|January 6, 2006
Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern ItalyWalter Fries, Maria C Renda, Maria A Lo Presti, et al.Journal of Crohn'S & Colitis|September 24, 2011
Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel diseaseMarco Daperno, Fabiana Castiglione, Lissy de Ridder, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's diseaseFabio Salvatore Macaluso, Mauro Grova, Marica Saladino, et al.Biomedicines|March 28, 2025
Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease PatientsMichelangelo Rottura, Igor Pirrotta, Domenico Antonio Giorgi, et al.Diagnostics (Basel, Switzerland)|December 11, 2025
TNF-α Quantification in Formalin-Fixed Paraffin-Embedded Tissues as a Predictive Biomarker in Ulcerative ColitisAnna Viola, Walter Giuseppe Giordano, Rasmus Goll, et al.Journal of Crohn'S & Colitis|April 23, 2020
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case SeriesFrank M Phillips, Bram Verstockt, Shaji Sebastian, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2018
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective studyAnna Viola, Daniela Pugliese, Sara Renna, et al.Research in Psychotherapy (Milano)|April 3, 2025
Defense mechanisms and inflammatory bowel diseases: a narrative reviewOrlando Silvestro, Carmelo M Vicario, Ludovico Costa, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel DiseasePaolo Gionchetti, Fernando Rizzello, Vito Annese, et al.Cancers|October 29, 2025
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter StudyRoberto Mancone, Benedetto Neri, Clara De Francesco, et al.Pageof 11